Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aimei Health Technology Co., Ltd. stock logo
AFJK
Aimei Health Technology
$44.91
-0.2%
$34.55
$6.75
$130.37
$274.83M0.4624,642 shs1,257 shs
EVOX
Evolution Global Acquisition
$10.00
0.0%
$9.99
$9.86
$10.09
$279.94MN/A66,185 shs25,000 shs
TVA
Texas Ventures Acquisition III
$10.53
+0.0%
$10.42
$9.98
$12.27
$280.67MN/A105,113 shs24,309 shs
UYSC
UY Scuti Acquisition
$10.52
-0.9%
$10.43
$9.89
$10.63
$70.24MN/AN/AN/A
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aimei Health Technology Co., Ltd. stock logo
AFJK
Aimei Health Technology
-10.24%-10.12%+72.82%-16.60%+274.45%
EVOX
Evolution Global Acquisition
-0.05%-0.10%+0.15%-0.60%+998,999,900.00%
TVA
Texas Ventures Acquisition III
+0.05%+0.33%+1.49%-2.00%+1,052,499,900.00%
UYSC
UY Scuti Acquisition
-0.43%+0.42%+1.48%+2.66%+1,057,399,900.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aimei Health Technology Co., Ltd. stock logo
AFJK
Aimei Health Technology
$44.91
-0.2%
$34.55
$6.75
$130.37
$274.83M0.4624,642 shs1,257 shs
EVOX
Evolution Global Acquisition
$10.00
0.0%
$9.99
$9.86
$10.09
$279.94MN/A66,185 shs25,000 shs
TVA
Texas Ventures Acquisition III
$10.53
+0.0%
$10.42
$9.98
$12.27
$280.67MN/A105,113 shs24,309 shs
UYSC
UY Scuti Acquisition
$10.52
-0.9%
$10.43
$9.89
$10.63
$70.24MN/AN/AN/A
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aimei Health Technology Co., Ltd. stock logo
AFJK
Aimei Health Technology
-10.24%-10.12%+72.82%-16.60%+274.45%
EVOX
Evolution Global Acquisition
-0.05%-0.10%+0.15%-0.60%+998,999,900.00%
TVA
Texas Ventures Acquisition III
+0.05%+0.33%+1.49%-2.00%+1,052,499,900.00%
UYSC
UY Scuti Acquisition
-0.43%+0.42%+1.48%+2.66%+1,057,399,900.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aimei Health Technology Co., Ltd. stock logo
AFJK
Aimei Health Technology
1.00
SellN/AN/A
EVOX
Evolution Global Acquisition
0.00
N/AN/AN/A
TVA
Texas Ventures Acquisition III
1.00
SellN/AN/A
UYSC
UY Scuti Acquisition
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest UYSC, AFJK, TVA, and EVOX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/1/2026
TVA
Texas Ventures Acquisition III
Reiterated RatingSell (D-)
5/1/2026
UYSC
UY Scuti Acquisition
Reiterated RatingSell (D-)
3/27/2026
Aimei Health Technology Co., Ltd. stock logo
AFJK
Aimei Health Technology
Reiterated RatingSell (D+)
(Data available from 5/6/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aimei Health Technology Co., Ltd. stock logo
AFJK
Aimei Health Technology
N/AN/A$0.29 per share153.85($0.16) per shareN/A
EVOX
Evolution Global Acquisition
N/AN/AN/AN/AN/AN/A
TVA
Texas Ventures Acquisition III
N/AN/AN/AN/AN/AN/A
UYSC
UY Scuti Acquisition
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aimei Health Technology Co., Ltd. stock logo
AFJK
Aimei Health Technology
$2.55M$0.21213.85N/AN/AN/A-55.45%2.71%N/A
EVOX
Evolution Global Acquisition
N/AN/AN/AN/AN/AN/AN/AN/AN/A
TVA
Texas Ventures Acquisition III
N/AN/AN/AN/AN/AN/AN/AN/AN/A
UYSC
UY Scuti Acquisition
N/AN/AN/AN/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Aimei Health Technology Co., Ltd. stock logo
AFJK
Aimei Health Technology
N/AN/AN/AN/AN/A
EVOX
Evolution Global Acquisition
N/AN/AN/AN/AN/A
TVA
Texas Ventures Acquisition III
N/AN/AN/AN/AN/A
UYSC
UY Scuti Acquisition
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aimei Health Technology Co., Ltd. stock logo
AFJK
Aimei Health Technology
N/A
0.01
0.01
EVOX
Evolution Global Acquisition
N/AN/AN/A
TVA
Texas Ventures Acquisition III
N/AN/AN/A
UYSC
UY Scuti Acquisition
N/AN/AN/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Aimei Health Technology Co., Ltd. stock logo
AFJK
Aimei Health Technology
N/A6.12 million5.97 millionN/A
EVOX
Evolution Global Acquisition
228.00 millionN/AN/A
TVA
Texas Ventures Acquisition III
226.67 millionN/AN/A
UYSC
UY Scuti Acquisition
36.68 million6.48 millionN/A

Recent News About These Companies

UY Scuti Acquisition Corp. Issues Promissory Note
UY Scuti Acquisition Corp. Delays Yearly Report

New MarketBeat Followers Over Time

Media Sentiment Over Time

Aimei Health Technology stock logo

Aimei Health Technology NASDAQ:AFJK

$44.90 -0.09 (-0.19%)
As of 10:52 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.

Evolution Global Acquisition NASDAQ:EVOX

$10.00 0.00 (-0.02%)
As of 10:27 AM Eastern
This is a fair market value price provided by Massive. Learn more.

We are a special purpose acquisition company incorporated on June 26, 2025 as a Cayman Islands exempted company and formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have not selected any business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. While we may pursue an acquisition in any industry, we intend to focus our search on companies that own, operate, or are developing assets in the critical minerals sector that are fundamental to the economic and national security interests of the United States. We intend to identify companies with critical resource infrastructure, in order to accelerate America’s safe and secure energy future, accelerate electrification and grid expansion, support the what we expect to be an upcoming digital infrastructure revolution, reduce foreign reliance on mineral supply chains, and drive industrial resurgence. We expect to target companies involved in the exploration, processing, production, and domestic refining and recycling of minerals essential to national defense, clean energy independence, and technological leadership, preferably with enabling technologies. We have not selected any specific business combination target, and we have not, nor has anyone on our behalf, engaged in any substantive discussions, directly or indirectly, with any business combination target. We believe our management team has the skills and experience to identify, evaluate and consummate a business combination and is positioned to assist businesses we acquire. However, our management team’s network and investing and operating experience do not guarantee a successful initial business combination. The members of our management team are not required to devote any significant amount of time to our business and are concurrently involved with other businesses. There is no guarantee that our current officers and directors will continue in their respective roles, or in any other role, after our initial business combination, and their expertise may only be of benefit to us until our initial business combination is completed. Past performance by our management team is not a guarantee of success with respect to any business combination we may consummate. Our executive offices are located in Farmers Branch, TX.

Texas Ventures Acquisition III NASDAQ:TVA

$10.52 +0.01 (+0.05%)
As of 10:29 AM Eastern
This is a fair market value price provided by Massive. Learn more.

We are a newly incorporated Cayman Islands exempted company structured as a blank check company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. To date, our efforts have been limited to organizational activities and activities related to this offering. We have not selected any potential business combination target, and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any potential target regarding entering into a business combination with us. While we may pursue an initial business combination target in any business, industry or geographical location, we intend to focus our search on targets focused on industrial technology, specifically companies implementing advanced technologies including software, mobile and IoT applications, digital and energy transition and consolidation, logistics and transportation, cloud and cyber communications as well as high bandwidth services, including LTE, remote sensing and 5G communications into the industrial sector. Our management team believes that the adoption of technology in the industrial sectors has traditionally evolved at a slower pace than most other industries. Our management team believes that this is due to large companies that have entrenched and siloed management teams and decision processes which discourage collaboration and adoption of new technologies. As such, many systems and practices are outdated and lack the efficiencies critical for long-term success in a technology enabled world. The accelerated need for advanced technologies such as artificial intelligence (“AI”), remote and cloud management, visibility and analytics, as well as carbon capture and the general industrial internet of things (“IIoT”) capabilities for the industrial sectors. Consequently, our management believes that many customers and enterprises are actively embracing such technologies and that there are significant opportunities to pursue a business combination. Our executive offices are located in Houston, Texas.

UY Scuti Acquisition NASDAQ:UYSC

$10.52 -0.10 (-0.94%)
Closing price 07:55 AM Eastern
Extended Trading
$10.52 0.00 (0.00%)
As of 07:55 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

UY Scuti Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on January 18, 2024 and is headquartered in New York, NY.